Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Kevin Outterson

A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All

scientific article published on 01 June 2018

A shot in the arm for new antibiotics

scientific article published on 01 October 2019

Accelerating global innovation to address antibacterial resistance: introducing CARB-X.

scientific article published on 29 July 2016

An international legal framework to address antimicrobial resistance

scientific article published in February 2015

Antibiotic development - economic, regulatory and societal challenges

scientific article published on 19 November 2019

Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach.

scientific article published on April 2016

Antimicrobial Resistance: The Authors Reply.

scientific article

Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009.

scientific article published on January 2013

Clinical trial transparency--antidote to weaker off-label-promotion rules?

scientific article published on 01 July 2014

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.

scientific article

Designing development programs for non-traditional antibacterial agents

scientific article published on 31 July 2019

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

scientific article

Disease management: legal strategies for the next generation of managed care

scientific article published on 01 January 1998

Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship.

scientific article published on 7 September 2017

Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization

scientific article published on 20 February 2020

Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals ⬇️

scientific article published on September 1, 2010

Foreword--Will HPV vaccines prevent cervical cancers among poor women of color?: global health policy at the intersection of human rights and intellectual property law

scientific article published on 01 January 2009

Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive Policy

scientific article published on May 2016

GP corporatisation: lessons to be learned ⬇️

scientific article published on October 15, 2001

Higher First Amendment hurdles for public health regulation.

scientific article published on 3 August 2011

How Medicare could get better prices on prescription drugs.

scientific article published on 30 July 2009

INTRODUCTION: What Will It Take to Address the Global Threat of Antibiotic Resistance?

scientific article published in June 2015

Improving antibiotic markets for long-term sustainability

scientific article published on 01 January 2011

Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

scientific article published on 5 April 2018

International cooperation to improve access to and sustain effectiveness of antimicrobials

scientific article

Introduction and geographic availability of new antibiotics approved between 1999 and 2014

scientific article published in PLoS ONE

Introduction: pharmaceutical innovation: law & the public's health

scientific article published on 01 January 2009

Market watch: Innovation in the preclinical antibiotic pipeline.

scientific article published on 6 October 2017

Market-based licensing for HPV vaccines in developing countries

scientific article published on 01 January 2008

Patent buy-outs for global disease innovations for low- and middle-income countries.

scientific article published in January 2006

Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.

scientific article

Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015.

scientific article published on 31 May 2016

Punishing health care fraud--is the GSK settlement sufficient?

scientific article published on 12 September 2012

Questions about the 10 x '20 Initiative

scientific article published on 01 September 2010

Regulating compounding pharmacies after NECC.

scientific article

Repairing the broken market for antibiotic innovation

scientific article published on February 2015

Should access to medicines and TRIPS flexibilities be limited to specific diseases?

scientific article published on 01 January 2008

Smoking and the First Amendment ⬇️

scientific article published on 07 December 2011

The Drug Quality and Security Act--mind the gaps.

scientific article

The Fight Against Multidrug-Resistant Bacteria

scientific article published on 01 January 2017

The global preclinical antibacterial pipeline

scientific article published on 19 November 2019

To the G20: incentivising antibacterial research and development.

scientific article published on 6 July 2017

Towards new business models for R&D for novel antibiotics.

scientific article published on 25 March 2011

Tragedy and remedy: reparations for disparities in black health.

scientific article

What Will It Take to Address the Global Threat of Antibiotic Resistance?

scientific article published in June 2015

Will longer antimicrobial patents improve global public health?

scientific article published in August 2007

Paulina is supported by:

About Paulina

Help